These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18298051)

  • 21. [Use if PCR for the characterization of strains].
    Berrón Morato S; Vázquez Moreno JA
    Rev Esp Salud Publica; 1998; 72(5):437-8. PubMed ID: 9951339
    [No Abstract]   [Full Text] [Related]  

  • 22. Coadministration of the cyanobacterial lipopolysaccharide antagonist CyP with antibiotic inhibits cytokine production by an in vitro meningitis model infected with Neisseria meningitidis.
    Oliver R; Staples KJ; Heckels J; Rossetti C; Molteni M; Christodoulides M
    J Antimicrob Chemother; 2012 May; 67(5):1145-54. PubMed ID: 22334603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Demonstration of lipooligosaccharide immunotype and capsule as virulence factors for Neisseria meningitidis using an infant mouse intranasal infection model.
    Mackinnon FG; Borrow R; Gorringe AR; Fox AJ; Jones DM; Robinson A
    Microb Pathog; 1993 Nov; 15(5):359-66. PubMed ID: 7912406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a UK outbreak strain of Neisseria meningitidis with a DNA probe.
    Knight AI; Cartwright KA; McFadden J
    Lancet; 1990 May; 335(8699):1182-4. PubMed ID: 1971036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uncloaking the meningococcus: dynamics of carriage and disease.
    Stephens DS
    Lancet; 1999 Mar; 353(9157):941-2. PubMed ID: 10459897
    [No Abstract]   [Full Text] [Related]  

  • 26. Serogrouping of non-interpretable Neisseria meningitidis carriage strains, using rapid diagnostic tests.
    Hamidou AA; Djibo S; Mamane AE; Moussa A; Chanteau S
    Trans R Soc Trop Med Hyg; 2008 Jan; 102(1):99-100. PubMed ID: 17976669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changing epidemiology of Infant Meningococcal Disease after the introduction of meningococcal serogroup C vaccine in Italy, 2006-2014.
    Stefanelli P; Fazio C; Neri A; Boros S; Renna G; Pompa MG;
    Vaccine; 2015 Jul; 33(31):3678-81. PubMed ID: 26087297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meningitis caused by a lipopolysaccharide deficient Neisseria meningitidis.
    Piet JR; Zariri A; Fransen F; Schipper K; van der Ley P; van de Beek D; van der Ende A
    J Infect; 2014 Oct; 69(4):352-7. PubMed ID: 24932738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the inflammatory response of brain microvascular and peripheral endothelial cells following infection with Neisseria meningitidis.
    Dick J; Hebling S; Becam J; Taha MK; Schubert-Unkmeir A
    Pathog Dis; 2017 Jul; 75(5):. PubMed ID: 28379411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changing epidemiology of meningococcal invasive disease in the Czech republic caused by new clone Neisseria meningitidis C:2a:P1.2(P1.5), ET-15/37.
    Krizova P; Musilek M
    Cent Eur J Public Health; 1995 Nov; 3(4):189-94. PubMed ID: 8903519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic Surveillance of 4CMenB Vaccine Antigenic Variants among Disease-Causing Neisseria meningitidis Isolates, United Kingdom, 2010-2016.
    Rodrigues CMC; Lucidarme J; Borrow R; Smith A; Cameron JC; Moxon ER; Maiden MCJ
    Emerg Infect Dis; 2018 Apr; 24(4):673-682. PubMed ID: 29553330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Invasive meningococcal disease due to a non-capsulated Neisseria meningitidis strain in a patient with IgG4-related disease.
    Kurose S; Onozawa K; Yoshikawa H; Yaita K; Takahashi H; Shimono N; Nagasaki Y
    BMC Infect Dis; 2018 Apr; 18(1):146. PubMed ID: 29606119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A rare case of meningitis due to Neisseria meningitidis group 29E.
    Kerr D; Hooper WL; Jones DM
    J Infect; 1986 Sep; 13(2):147-9. PubMed ID: 3093590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A patient with meningococcal meningitis and deficiency of the 7th factor of the complement system].
    Moolenaar W; Pott Hofstede D; Hack CE; Hannema AJ
    Ned Tijdschr Geneeskd; 1987 May; 131(20):866-8. PubMed ID: 3108681
    [No Abstract]   [Full Text] [Related]  

  • 35. Australian Meningococcal Surveillance Programme, 1 April to 30 June 2017.
    Lahra MM; Enriquez R
    Commun Dis Intell Q Rep; 2017 Sep; 41(3):E241-E242. PubMed ID: 29720073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meningococcal septicaemia in a C6-deficient patient and effects of plasma transfusion on lipopolysaccharide release.
    Lehner PJ; Davies KA; Walport MJ; Cope AP; Würzner R; Orren A; Morgan BP; Cohen J
    Lancet; 1992 Dec; 340(8832):1379-81. PubMed ID: 1360091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of Meningococcal B Vaccine against Endemic Hypervirulent Neisseria meningitidis W Strain, England.
    Ladhani SN; Giuliani MM; Biolchi A; Pizza M; Beebeejaun K; Lucidarme J; Findlow J; Ramsay ME; Borrow R
    Emerg Infect Dis; 2016 Feb; 22(2):309-11. PubMed ID: 26811872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meningococcal disease and future drug targets.
    Gammelgaard LK; Colding H; Hartzen SH; Penkowa M
    CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):140-5. PubMed ID: 20874698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A first meningococcal meningitis case caused by serogroup X Neisseria meningitidis strains in China.
    Chen C; Zhang TG; He JG; Wu J; Chen LJ; Liu JF; Pang XH; Yang J; Shao ZJ; Huang YC
    Chin Med J (Engl); 2008 Apr; 121(7):664-6. PubMed ID: 18466690
    [No Abstract]   [Full Text] [Related]  

  • 40. Endotoxin liberation associated with growth, encapsulation and virulence of Neisseria meningitidis.
    Andersen BM; Solberg O
    Scand J Infect Dis; 1988; 20(1):21-31. PubMed ID: 3129779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.